WallStreetZenWallStreetZen

NASDAQ: PBM
Psyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?

OverviewEarningsDividendOwnership

Insider buying vs selling

Have Psyence Biomedical Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Polar Asset Management Partners Inc10% Owner2023-07-11130,000$11.07
$1.44MSell

1 of 1

PBM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBM insiders and whales buy or sell their stock.

PBM Shareholders

What type of owners hold Psyence Biomedical Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Marc Gregory Balkin55.67%7,455,000$5.95MInsider
Newcourt Spac Sponsor LLC6.87%920,000$734.16kInsider
Polar Asset Management Partners Inc3.96%530,000$422.94kInsider
Cantor Fitzgerald L P1.40%187,000$149.23kInstitution
Westchester Capital Management LLC0.76%101,291$80.83kInstitution
Shaolin Capital Management LLC0.69%92,345$73.69kInstitution
Periscope Capital Inc0.56%75,000$59.85kInstitution
Walleye Capital LLC0.12%16,000$12.77kInstitution
Clear Street LLC0.09%12,000$9.58kInstitution
Geode Capital Management LLC0.08%10,488$8.37kInstitution

1 of 2

PBM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBM3.69%66.53%Net Selling
GRTX23.78%57.19%Net SellingNet Selling
BNOX0.07%0.00%
MNPR1.40%98.60%Net SellingNet Selling
COEP13.11%41.01%Net Buying
View Top Biotech Stocks

Psyence Biomedical Stock Ownership FAQ

Who owns Psyence Biomedical?

Psyence Biomedical (NASDAQ: PBM) is owned by 3.69% institutional shareholders, 66.53% Psyence Biomedical insiders, and 29.78% retail investors. Marc Gregory Balkin is the largest individual Psyence Biomedical shareholder, owning 7.46M shares representing 55.67% of the company. Marc Gregory Balkin's Psyence Biomedical shares are currently valued at $6.26M.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.